Loading...
Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma
Osteosarcoma (OS) is a bone cancer mostly occurring in pediatric population. Current treatment regime of surgery and intensive chemotherapy could cure about 60%–75% patients with primary osteosarcoma, however only 15% to 30% can be cured when pulmonary metastasis or relapse has taken place. Hence, n...
Na minha lista:
| Udgivet i: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4848962/ https://ncbi.nlm.nih.gov/pubmed/27058531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17040506 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|